Dyadic International Inc
NASDAQ:DYAI
Dyadic International Inc
Total Liabilities
Dyadic International Inc
Total Liabilities Peer Comparison
Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors
Company | Total Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Dyadic International Inc
NASDAQ:DYAI
|
Total Liabilities
$8.2m
|
CAGR 3-Years
47%
|
CAGR 5-Years
45%
|
CAGR 10-Years
-4%
|
|
Abbvie Inc
NYSE:ABBV
|
Total Liabilities
$140.9B
|
CAGR 3-Years
1%
|
CAGR 5-Years
17%
|
CAGR 10-Years
19%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Total Liabilities
$38.8B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
10%
|
|
Amgen Inc
NASDAQ:AMGN
|
Total Liabilities
$88B
|
CAGR 3-Years
18%
|
CAGR 5-Years
11%
|
CAGR 10-Years
7%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Total Liabilities
$5.4B
|
CAGR 3-Years
20%
|
CAGR 5-Years
24%
|
CAGR 10-Years
19%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Total Liabilities
$7.4B
|
CAGR 3-Years
8%
|
CAGR 5-Years
17%
|
CAGR 10-Years
22%
|
See Also
What is Dyadic International Inc's Total Liabilities?
Total Liabilities
8.2m
USD
Based on the financial report for Mar 31, 2024, Dyadic International Inc's Total Liabilities amounts to 8.2m USD.
What is Dyadic International Inc's Total Liabilities growth rate?
Total Liabilities CAGR 10Y
-4%
Over the last year, the Total Liabilities growth was 306%. The average annual Total Liabilities growth rates for Dyadic International Inc have been 47% over the past three years , 45% over the past five years , and -4% over the past ten years .